News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medrad, Inc./Possis Medical, Inc. (POSS) to Co-Sponsor ATTRACT Trial, Evaluating Long-Term Benefits of New Treatments for Deep Vein Thrombosis



9/22/2008 1:04:43 PM

PITTSBURGH--(BUSINESS WIRE)--MEDRAD Interventional/Possis, the new endovascular-focused division of MEDRAD, INC., today announced that it is a sponsor of the ATTRACT trial which will evaluate the long-term benefits of using the company’s AngioJet® Rheolytic™ Thrombectomy System in combination with clot-softening drugs to provide more rapid endovascular treatment of Deep Vein Thrombosis (DVT).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES